Enhance genius behind the genes.
LATEST NEWS
CarthaGenetics® worked with Bayer Turkey to establish an interactive value demonstration tool in SPAF patients based on health economics and outcome researches.
It is the first time a pharmaceutical company conducts an interactive value demonstration tool for presenting the value of products to physicians in Turkey. We hope to see more creative and interactive examples in near future.
For any question concerning this, please contact our Market Access Team at kockaya@carthagenetics.com, sharaf@carthagenetics.com or cavus@carthagenetics.com.
May 5th, 2018 Istabul, Turkey and Pully, Switzerland: Nobel Ilac and CarthaGenetics® announce collaboration for rare diseases in North Africa area.
Nobel Ilac is a full-cycle Turkish pharmaceutical company founded in 1964, producing world-class pharmaceuticals for human health. Nobel Ilac provides a global presence of outstanding, reliable and accessible products for human health.
CarthaGenetics® is focusing on finding innovative early patients access to medicines for supplying the unmet needs and is a pioneer with having the broadest experience in the field of rare diseases, gene therapies and biosimilars.
Nobel Ilac and CarthaGenetics® announce the collaboration for rare diseases in North Africa area.
For any question concerning this, please contact Burak Levent, at Nobel Ilac burak.levent@nobel.com.tr or Philippe Carteron de Balmont CEO, at CarthaGenetics® phcarteron@carthagenetics.com“
Health Technology Assessment Report about Hypertermic Intraperitoneal Chemotherapy (HIPEC)
Health Tchnology Assessment (HTA) Report about Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has been published by Ministry of health of Turkey under authorship of Dr. Guvenc Kockaya and contribution of Filiz Cavus Sen.
CarthaGenetics® will move forward to support governmental bodies and private institutions for health technology assessment projects.
Find it at :
February 15th 2018 : New CarthaGenetics® office in Istanbul
After having served the Turkish rare diseases community for many years from Ankara, we are happy to announce that CarthaGenetics® is now also established in Istanbul with its new office in.
Nidakule Kozyatagi
Kozyatagi Mahallesi
Degirmen Sk. 18/19B, Kat 10
34742 Kadikoy/Istanbul
Turkey
We look forward to receiving you there!
November 21th, 2017 Moscow, Russia and Pully, Switzerland: Nativa LLC and CarthaGenetics® announce collaboration in North Africa area
Nativa LLC is a full-cycle Russian pharmaceutical company founded in 2010, developing and producing world-class complex medicaments essential for human health. It focuses on oncology, pulmonology, multiple sclerosis and other fields.
CarthaGenetics® is focusing on finding innovative early patients access to medicines for treating unmet needs and is now a pioneer with one of the broadest experience in the field of rare diseases, gene therapies and biosimilars.
For any question concerning this please contact Vladimir A. Mefodovskiy, CDO at Nativa LLC v.mefodovskiy@nativa.pro or Philippe Carteron de Balmont CEO, at CarthaGenetics® phcarteron@carthagenetics.com“
Results of the Survey about the Factors Impacting on Community Pharmacy Efficiency
Turkish health sector has been changed completely with the Health Transformation Project lead by Ministry of Health. In this process of change, healthcare providers have become more competitive in healthcare market. As a result of project the health expenditures has been
increased and policy makers implemented policies for controling this increase. These policies made the competitive environment even more challenging. Community pharmacy, one of the most important actors of the healthcare sector and one of the first steps in the health service access of the society, confronts many difficulties, especially financial in this competitive and challenging market. Despite these difficulties, community pharmacists continue to practice for community pharmacy is a profession, an art, and a doing good. In this process, it is necessary to evaluate the difficulties of community pharmacists and what needs to be done to cope with these difficulties. The study that emerged from this point of view was made by Bursa Pharmacist Chamber through CarthaGenetics Consulting firm. While trying to assess the efficacy of free pharmacists in the study, it was aimed to identify the concerns for sustainable pharmacy and to find possible recommendations for them. We hope that the study will shed light on the Turkish pharmacy community and form the basis for further studies.
Keep track, keep contact. For more questions please email to kockaya@carthagenetics.com
Pharmaceutical Market Access in Developed Market is now pre-order on Amazon!!
The book titled as “Pharmaceutical Market Access in Developed Markets” under Dr. Guvenc Kockaya (CarthaGenetics market Access Director) and Prof. Albert Wert heimer’s editorialship has been published for pre-order on Amazon.
Market access is the process by which a pharmaceutical company gets its product available on the market after having obtained a marketing authorization from a regulatory agency and by which the product becomes available for all patients for whom it is indicated as per its marketing authorization. Since there are cultural differences among countries, any Market Access strategy needs to be culturally sensitive. Pharmaceutical Market Access in emerging markets has been extensively discussed in the previous book, published in 2016. The present book focuses on developed markets with the goal of helping students, academics industry personnel and government workers and decision makers understand the environment in developed markets.
Health Technology Assessment Report about Hypertermic Intraperitoneal Chemotherapy (HIPEC)
Draft HTA report about HIPEC under Dr. Guvenc Kockaya`s authorship has been published by Ministry of Health of Turkey. The report will be online up to 9th November 2017 for getting comments from community. The final report will be published after review of comments.Keep track, keep contact. For further questions: kockaya@carthagenetics.com, sharaf@carthagenetics.com
Monday September 4th – Exciting News from Spain !
As a growing company, a new chapter has begun for CarthaGenetics® Iberica.
You can now find us from today at our new location at: CarthaGenetics® Iberica Paseo de la Castellana 141, Cuzco IV, 28046 Madrid Spain. Telephone: +34 915726644
Email: madrid@carthagenetics.com. Do not hesitate to contact us!
May 16th, 2017 – CarthaGenetics® will be working on three projects in Turkey in support of governmental healthcare priorities
CarthaGenetics®, who enjoys a multiyear presence in Turkey with a team of market access experts, is committed to supporting government and non-government authorities with building health economics and health technology assessment (HTA) environments, leading to a solid and sustainable healthcare system. In this context, CarthaGenetics® announced today that it had signed an agreement with the Turkish Ministry of Health to drive and implement three different projects to support the diverse governmental healthcare priorities.
In the first agreement signed with the Ministry of Health of Turkey, CarthaGenetics® will prepare a comprehensive health technology report on the “Importance, Development and Production of Disposable Circumcision Instruments“ in collaboration with local partner Turkiye Klinikleri. This project will roll out over a period of 10 months with 8 Turkey-based local experts and will deliver hands-on recommendations to the Ministry.
The second agreement signed between the CarthaGenetics® market access expert team and the Ministry of Health will lead to preparing a brief health technology report on the key topic of “Hyperthermic Intraperitoneal Chemotherapy (HIPEC)”. This project will roll out over a period of 7 months and will provide key directions to public decision makers of Turkey.
Finally, CarthaGenetics® will be conducting a regional survey for Bursa Ecza Odası in collaboration with Dr. Gulpembe Ergin in order to understand “Factors impacting the efficiency of pharmacy practice”. This study, initially focused on Bursa-based pharmacies, is meant to later model the way for all pharmacies across the country. This survey, recently kicked off, will be active until June 25th, 2017 and final results will be published in relevant congresses and journals.
For more information about these projects, please contact Güvenç Koçkaya, International Market Access Director, CarthaGenetics® at: kockaya@carthagenetics.com
May 2nd, 2017! Milestone for Imported Drugs in Turkey!
Turkish Social Security Institute is taking over the drug procurement procedure (for unauthorized and orphan drugs) as of May 2nd!In the last days of December 2016, Turkish Social Security Institute (SGK) announced that the institute will take over the procedure of drug procurement. Until now, this was managed by the Turkish Pharmacists Association (TEB). TEB was the only body entitled to import these drugs and had a well-set organization for the purchasing and distribution of the drug to the patient.
SGK changed its organizational structure and established a unit specifically for the procurement of unauthorized drugs in Turkey. As of May 2nd, SGK will be the main body to import these drugs. In order to have a smooth transition for the sake of the patients, SGK signed a contract with TEB for a certain period of time.
According to the new system, the cold-chain products will continue to be provided by TEB for the coming few months. Meanwhile, SGK is ensuring that adequate number of personnel are recruited and trained for its warehouse. The brand-new products that will enter the market for the 1st time will directly be procured by SGK.
BIG CHANGES are on the way for the off-label drug procurement in Turkey!
Turkish Social Security Institute (SGK) made structural changes to take over the procurement of drugs without market authorization in Turkey from TEB (Turkish Pharmacists Association). SGK will import these products, which are under Named Patient Sales Program in Annex 4C, as of May 2nd, 2017. They have a new system where prices are being reviewed again.
We, CarthaGeneticsÒ Team, provide services to companies who want to be a part of the current and upcoming NPS market access process in Turkey. For more information, you can reach us at kaya@carthagenetics.com
Turkey is one of the countries in Europe and Middle East with the highest number of population (80 million) and gathers all its citizens under the umbrella of the government health insurance system. This seems to bring a real burden on the social security system. To use the healthcare budget, ministry gathers prices from 5 European countries as reference and takes the lowest price for pricing calculations. With the obligatory discounts and fixed exchange rate, getting a market authorization for a drug in Turkey means 65% discount for the manufacturer.
On the other hand, being one of the rare countries with a broad social security coverage, Turkey opens its doors wide to rare diseases and orphan drugs. Rate of consanguineous marriages being 22%, Turkey seems to be hosting rare diseases more than many other countries.
For unauthorized drugs and orphan drugs, TEB (Turkish Pharmacists Association) has been the only procurement body for many years. They played the nonprofit procurement company role in delivering this kind of drugs so that Named Patient Sales pathway is a smooth process.
Since December 2016, Turkish Social Security Institute (SGK) has been debating on delivering the drugs itself. Beginning of this year, they finalized the debates and started preparation; by changing the SGK structure as the first step. In the new structure, SGK established a new department called “Drug Procurement Department” and assigned officers to work on the new procedure and its management. The project will go live on May 2nd, 2017.
The new structure of Social Security Institute places the patient in the center. The system enables the drug to be delivered to the patients without difficulties. Ministry of Health and Social Security Institute will be cooperating in this process.
September 5th, 2016 – CarthaGenetics® will help Race Oncology with EU market development of chemotherapy drug Bisantrene
Australian biotechinnovator race
Oncology signs
agreement with
CarthaGenetics for EU
market development of
chemotherapy
drug Bisantrene
CarthaGenetics® announced today that it had signed an agreement with the Australian company race Oncology to expedite the launch of the company’s Named Patient Program (NPP) in Europe, and to distribute and sell Bisantrene under the program. Under the agreement, CarthaGenetics® will be responsible for market development and awareness of Bisantrene prior to launch and all necessary regulatory approvals to allow Bisantrene to be sold in each target NPP country. CarthaGenetics® will also be responsible for all storage, distribution, invoicing, sales and customer service of Bisantrene in each country under the Named Patient Program.
CarthaGenetics® Founder and CEO, Philippe Carteron de Balmont, said: “At CarthaGenetics, we are proud to help Race Oncology launch Bisantrene and achieve success in the European market. Named Patient access regulations in individual European countries allow patients access to innovative therapies under development. Given Bisantrene’s safety profile and clinical data, it is well-suited to a Named Patient sales Program in those countries”. The agreement will also provide Race with all the infrastructure and logistical support needed to sell Bisantrene in various European countries. In all markets outside Europe, Race Oncology is now actively pursuing licensees for Bisantrene. “CarthaGenetics are experts in Named Patient Program sales in Europe,” said Managing Director, Peter Molloy. “Their expertise will help ensure Bisantrene gets to market rapidly and achieves its full sales potential.”
To that end, both companies will be attending the BioPharm America conference in Boston on 13-15 September, 2016.
For more information, contact: phcarteron@carthagenetics.com
UPCOMING EVENTS
CarthaGenetics® at The 16th Congress of SOFREMIP, Brest
CarthaGenetics® will attend to the 16th Congress of SOFREMIP (Société Francophone de Rhumatologie et de Médecine Interne Pédiatrique/French speaking Congress of Pediatric Rhumatology and Pediatric Internal Medecine) in Brest, France on 17-18 May.
Please do not hesitate to contact us!
Philippe Carteron our CEO at (phcarteron@carthagenetics.com) and/or Stéphane Campana at (campana@carthagenetics.com)
we would be happy to meet you there!
CarthaGenetics® at The 9th African Congress of Rheumatology and The 18th Algerian Congress of Rheumatology, Algiers
CarthaGenetics® is participating to the 9th African Congress of Rheumatology and the 18th Algerian Congress of Rheumatology from the 3rd to 5th May, in Hotel Sheraton Algiers, Algeria.
Feel free to get in touch with our team:
-Mrs. Imane Belala (belala@carthagenetics.com)
-Dr. Aroussi Bidani (bidani@carthagenetics.com)
Looking foward to meeting you there !
CarthaGenetics® at The 12th Meeting of Pediatrics, Tlemcen
CarthaGenetics® is participating to the 12th Meeting of Pediatrics from the 3rd to 4th May, in Hotel Renaissance Tlemcen, Algeria. The meeting is oganized by APSET association.
Feel free to get in touch with our team:
-Dr. Samira Benmansour (benmansour@carthagenetics.com)
-Mr Badreddine Souici (souici@carthagenetics.com)
Looking foward to meeting you there !
CarthaGenetics® aux 3ème Congrès National De Neurologie Pédiatrique et 17èmes Journées de Neurologie Pédiatrique, Tunis
CarthaGenetics® a le plaisir de vous annoncer sa participation aux 3ème Congrès National De Neurologie Pédiatrique et 17èmes Journées De Neurologie Pédiatrique, organisés par l’Association Tunisienne De Neurologie De l’Enfant et de l’Adolescent (ATNEA), en collaboration avec les Urs de Neurologie Pédiatrique de Tunis et de Sfax, du 20 au 21 Avril, à l’hôtel Golden Tulip El Mechtel-Tunis.
CarthaGenetics® sera representée par:
-Mr Philippe Carteron De Balmont, CEO (phcarteron@carthagenetics.com)
-Dr. Aroussi Bidani, International Medical Director (bidani@carthagenetics.com)
N’hésitez pas à nous contacter!
CarthaGenetics® at Turkish Clinical Immunology Congress, Antalya
CarthaGenetics® is participating to the 4th Turkish Clinical Immunology Congress from the 11th to 14th April in Antalya.
Feel free to get in touch with our team:
Dr. Aroussi Bidani (bidani@carthagenetics.com)
Dr. Guvenc Kockaya (kockaya@carthagenetics.com)
Mrs Filiz Cavus (cavus@carthagenetics.com)
Looking foward to meeting you there !
CarthaGenetics® at Pharma Synergy Conference, Rome
CarthaGenetics® will attend Pharma Synergy Conference on 22nd-24th March, 2018 in Rome.
Our Market Access Dir. Guvenc Kockaya will give a speach about MA in Turkey,
Algeria and Tunisia.
For a meeting please contact (kockaya@carthagenetics.com).
Looking foward to meeting you there !
CarthaGenetics® at Bio-Europe Spring, Amsterdam
As each year CarthaGenetics® will attend Bio-Europe Spring on 12th to 14th March 2018 in Amsterdam.
If you would like to arrange a one-to-one meeting please send an email to our CEO, Mr. Philippe Carteron de Balmont (phcarteron@carthagenetics.com) or to our BD Director, Dr. Amir Sharaf (sharaf@carthagenetics.com
Looking foward to meeting you there !
CarthaGenetics® at RE(ACT)Congress, Bologna
CarthaGenetics® is attending RE(ACT) Congress from the 7th to 8th of March in Bologna, Italy. Our team, represented by Mr. Riccardo Lang, Country Director Italy and Dr. Stéphane Campana, Country Manager Italy, would be glad to meet you there and exchange insights about your programs and needs during and around the main event’s activities. Should you like to arrange an appointment, you can contact us either on (lang@carthagenetics.com) or (campana@carthagenetics.com
Looking foward to meeting you there !
CarthaGenetics® at World Symposium 2018, San Diego
CarthaGenetics® will attend World Symposium™ 2018 on Lysosomal Diseases in San Diego which will be held from 5th to 9th February 2018 in San Diego.
Our team has been pionniering for more that 22 years on each new treatments on LSD: Gaucher, Fabry, MPSI, MPSII, MPSVI, MPSVII, LAL deficiency, Farber, Cystonisis for the major stakeholders, Genzyme, TKT/Shire, BioMarin, Ultragenyx, Isu Abxis, Synagenva / Alexion, Raptor/ Horizon, Amicus.
Please contact us to set up a meeting with our International Medical Director, Dr. Aroussi BIDANI (bidani@carthagenetics.com) or with me (phcarteron@carthagenetics.com
Looking foward to meeting you there !
CarthaGenetics® at J.P. Morgan 36th Annual Healthcare Conference, San Francisco, CA – USA
San Francisco is hosting JP Morgan conference which will be held at Westin St. Francis in San Francisco, CA from 8th to 11th January 2018. As the orphan drugs consultancy companion, We will be there. If you are interested in patients finding , early access programs in Europe or market access please contact our Director of Business Development Dr Amir Sharaf at: sharaf@carthagenetics.comand or our Market Access Director Dr Güvenç Koçkaya at: kockaya@carthagenetics.com
Full details of the conference can be found on the website: https://www.jpmorgan.com
CarthaGenetics® à la Journée Scientifique, Tunis
CarthaGenetics®a le plaisir de vous annoncer sa participation à la Journée Scientifique le 2 Décembre 2017 à l’Hôtel l’Acropole – Les Berges du Lac à Tunis, organisée par L’Association Tunisienne d’Etude des Maladies Métaboliques Héréditaires (ATEMMH)
Les principaux thèmes sont :
1- Convulsions de l’enfant, retard mental : quand penser à une maladie héréditaire du métabolisme
2- Autisme dans les troubles métaboliques
3- Cas cliniques en ophtalmologie métabolique
Pour rencontrer notre CEO, Philippe Carteron de Balmont, merci de prendre contact avec lui à phcarteron@carthagenetics.com
Meet CarthaGenetics® at Bioalps Networking Day 2017, Lausanne
CarthaGenetics® will attend BioAlps Networking Day 2017 November 21, 2017. If you would like to arrange a meeting with us, do not hesitate to contact our CEO, Philippe Carteron de Balmont at phcarteron@carthagenetics.com
Full details of the congress can be found on the website:
Meet CarthaGenetics® at SEPD Symposium
CarthaGenetics® will attend SEPD Symposium on Early Access to Innovative Treatments in Istanbul, Turkey on 8th December 2017. Philippe Carteron will give a speech about Examples of Early Access especially from France, Italy & Spain. If you would like to arrange a meeting with us, do not hesitate to contact Philippe Carteron at phcarteron@carthagenetics.com
People can live healthier and longer with innovative treatments. According to the studies, access to innovative treatments should be as early as possible so that the benefit of the individual can be maximized. On the other hand, the cost of access to innovative treatments is increasing every year. Therefore, these costs, especially in countries like Turkey where the health system is financed by the government, become even more important for a sustainable health system.
In this context, “Early Access to Innovative Treatments Symposium” will be held at Boğaziçi University Campus of Istanbul on December 8, 2017 by the Association of Health Economics and Policy (SEPD), with the participation of patient groups, health workers, health service providers, academia and public employees.
Full details of the congress can be found on the website: http://sempozyum2017.sepd.org.
Meet CarthaGenetics® at the 3rd International Primary Immunodeficiencies Congress, Dubai
CarthaGenetics® will attend the 3rd International Primary Immunodeficiencies (IPIC 2017) Congress in Dubai, UAE from 8th to 10th November. If you would like to arrange a meeting with us, do not hesitate to contact Filiz Cavus at cavus@carthagenetics.com
Full details of the congress can be found on the website: https://www.ipic2017.com/
Meet CarthaGenetics® at ISPOR 20th Annual European Meeting
CarthaGenetics® will attend is going to attend to ISPOR 20th Annual European Meeting from 4 to 68November, 2017 in Glasgow, Scotland. The Market Access Team in the Kitchen is going to present posters titled as “MOBILE CARDIAC MONITORIZATION IS A COST-EFFECTIVE TOOL FOR THE DIAGNOSIS AND MANAGEMENT OF ATRIAL FIBRILLATION COMPARED TO HOLTER: A COST EFFECTIVENESS STUDY IN TURKEY”, “OVERVIEW OF INNOVATIVE MEDICINE SECTOR IN TURKEY” and “INCREASING TREND ON TURKISH UN-LICENCED MEDICINE MARKET : A GENERAL OVERVIEW ANALYSIS”.
Keep track, keep contact. For further questions : kockaya@carthagenetics.com, sharaf@carthagenetics.com
https://www.ispor.org/Event/index/2017Glasgow
Meet CarthaGenetics® at CPhI Worlwide
CarthaGenetics® will attend CPhI Worlwide from 24th to 26th October, 2017 in Messe Frankfurt, Germany. If you would like to arrange a meeting with us, do not hesitate to contact Dr. Aroussi Bidani at bidani@carthagenetics.com
website: https://www.cphi.com/europe/
Meet CarthaGenetics® at the 3rd Pediatric Genetics Symposium, Antalya, Turkey
CarthaGenetics® will attend the 3rd Pediatric Genetics Symposium from 11th to 13th October 2017 in Antalya, Turkey. If you would like to arrange a meeting with us, do not hesitate to contact Filiz Cavus at cavus@carthagenetics.com
Full details of the congress can be found on the website: http://www.cocukgenetik2017.com/
Meet CarthaGenetics® at 2017 Cell & Gene Meeting on the MESA, la Jolla, CA, USA, 4-6 October 2017
The Cell & Gene Meeting on the Mesa is a three-day conference bringing together senior executives and top decision-makers in the industry with the scientific community to advance cutting-edge research into cures. Philippe Carteron de Balmont, our CEO, will participate to this exciting event. Contact us if you would like us to arrange for a meeting with Philippe at azzouzi@carthagenetics.com.
Full details on the conference can be found on the meeting website: www.meetingonthemesa.com
September 26th, 2017 – Meet CarthaGenetics® BioPharm America
CarthaGenetics® will attend BioPharm America from 26th to 28th September 2017 in Sheraton hotel, Boston. If you would like to arrange a meeting with us, do not hesitate to contact our CEO Philippe Carteron de Balmont at phcarteron@carthagenetics.
Meet CarthaGenetics® at Drug Agencies and their Roles in the Promotion of R & D in Barcelona tomorrow, September 14th, 2017
Member of ASEBIO, The Spanish Bioindustry Association, CarthaGenetics® will attend this confernece on 14th September 2017 in Auditorio Del Parque de Investigacion Biomédica de Barcelona (C/Doctor Aiguader, 88), Barcelona Spain. If you would like to arrange a meeting with us, do not hesitate to contact Dr Samira Benmansour at at benmansour@carthagenetics.com .
http://www.asebio.com/en/event_item.cfm?iid=aemps_barcelona
PAST EVENTS
July 8th, 2017 – Meet CarthaGenetics® at the World Health Economics Congress
iHEA is going to organize World Health Economics Congress between 8-11 July 2017 in Boston, USA. Topic of congress is set as “Revolutions in the Economics of Health Systems”. The study titled as “Impact of Health Policies on Catastrophic Health Expenditures in Turkey” which was conducted by Guvenc Kockaya, MD,MSc,PhD.
Berna Tuncay, Aysun Aygun and Julide Yildirim will be presented as verbal presentation on 10 July 2017, 2.45-4.15 pm in “High/Catastrophic Health Cost” session, HAR-312 room.
In additonal, “Hospital Ownership” session on 9 July 2017, 2.45-4.15 pm in HAR-324 room will be lead by Guvenc Kockaya, MD,MSc,PhD.
CarthaGenetics® will be represented in the meeting as well. Please contact for further questions and discussions on kockaya@carthagenetics.com“
June 12th, 2017 – Meet CarthaGenetics® at SFEIM & CETL
CarthaGenetics® will attend SFEIM & CETL Congress from 12th to 14th June 2017 in Institut Culturel Bernard Magrez; Bordeaux, France. If you would like to arrange a meeting with us, do not hesitate to contact our CEO Philippe Carteron de Balmont at phcarteron@carthagenetics.
http://comnco.net/evenement/reunions-sfeim-cetl/
June 8th, 2017 – Meet CarthaGenetics®, Key Sponsor of REFRESH 2017
CarthaGenetics® will be a Key Event Sponsor of REFRESH 2017, the one-day annual conference organized by Labiotech.eu, Europe’s leading digital media for biotechnologies. CarthaGenetics® will naturally attend the 3rd edition of this event, held in Berlin, Germany on June 8th, 2017. If you would like to arrange a meeting with us, please contact us at our respective e-mail addresses:
– Philippe Carteron de Balmont at phcarteron@carthagenetics.com,
– Pascal Cerruti at pascal.cerruti@carthagenetics.com,
– Dr. Aroussi Bidani at bidani@carthagenetics.com
More information at: http://labiotech.eu/refresh/attendees/
May 14th, 2017 – Meet CarthaGenetics® at the 18th International Pharmaceutical Forum
CarthaGenetics® will attend the 18th International Pharmaceutical Forum from 14th to 16th May 2017 in Centre International Conferences, Algeria. If you would like to arrange a meeting with us, do not hesitate to contact Ms Imane BELALA at belala@carthagenetics.com
May 7th, 2017 – Meet CarthaGenetics® at the 3rd Annual Congress of the ESVM and 23rd IUA EuroChap Congress
CarthaGenetics® will attend the 3rd Annual Congress of the ESVM and 23rd IUA EuroChap Congress from 7th to 9th May 2017 in Graz, Austria . If you would like to arrange a meeting with us, do not hesitate to contact M. Riccardo Lang , at lang@carthagenetics.com or Dr. Aroussi Bidani at bidani@carthagenetics.com
May 5-6th, meet us in Tunisia, at the 11th Tunisian Congress of Inborn Errors of Metabolism
CarthaGenetics® will participate to the “11e Ecole Métabolique”, organized by the “‘Association Tunisienne d’Etudes des Maladies Métaboliques Héréditaires” (ATEMMH), on May 5-6, Hôtel Russelior, Hammamet, Tunisia. Do not hesitate to contact our CEO there, Philippe Carteron de Balmont (phcarteron@carthagenetics.com
May 4th, 2017 – Meet CarthaGenetics® at the Swiss Biotech Day 2017
CarthaGenetics® will attend the SWISS BIOTECH DAY, on May 4th, at Congress Center Basel, Switzerland. If you would like to arrange a meeting with us, do not hesitate to contact our CEO there, Philippe Carteron de Balmont , at phcarteron@carthagenetics.com
April 26th, 2017 – Meet CarthaGenetics® at IVEK 3rd International Convention of Pharmaceuticals and Pharmacies
CarthaGenetics® is participating in IVEK 3rd International Convention of Pharmaceuticals and Pharmacies from 26th to 29th April in WOW Istanbul Hotel & Convention Center, Istanbul, Turkey. If you would like to arrange a meeting with us, do not hesitate to contact Filiz Cavus at: cavus@carthagenetics.com
April 23rd, 2017 – Meet CarthaGenetics® at the 7th meeting of the French Angiogenesis Society
CarthaGenetics® is participating in the 7th meeting of the French Angiogenesis Society from 23rd to 25th April in Toulouse, France. If you would like to arrange a meeting with us, do not hesitate to contact Haythem Ammar at: ammar@carthagenetics.com
April 19th, 2017 – Meet CarthaGenetics® at the 19th National Pediatric Neurology Congress
CarthaGenetics® is participating in the 19th National Pediatric Neurology Congress at Cornelia Diamond Hotel Belek, in Antalya, Turkey, between April 19-23. If you would like to arrange a meeting with us, do not hesitate to contact Filiz Cavus at: cavus@carthagenetics.com or Mustapha Aydin at: aydin@carthagenetics.com
March 30th, 2017 – Meet CarthaGenetics® at the Pluripotent Stem Cells and Gene editing Symposium
CarthaGenetics® is participating to the Pluripotent Stem Cells and Gene editing Symposium, at University of Los Andes, Santiago, Chile, on March 30-31. If you would like to arrange a meeting with us, do not hesitate to contact our CEO there, Philippe Carteron de Balmont , at: phcarteron@carthagenetics.com
March 23rd, 2017 – Meet CarthaGenetics® at the 2nd Rare Diseases & Orphan Drugs Symposium
Carthagenetics® will attend the 2nd Rare Diseases & Orphan Drugs Symposium on 23 & 24 March, 2017 in Ankara, Turkey. If you would like to arrange a one-to-one meeting with us, please send an email to Erhan Kaya Riveraconteras at: kaya@carthagenetics.com or Mr. Guvenc Kockaya at: kockaya@carthagenetics.
Mr. Kockaya will present in the panel named as “Regulatury, Reimbursement and Budget Process for Orphan Medicines” on 24th March at 13.00-15.30, the presentation will focus on “possible budget impact of orphan medicines”.
http://www.nadirhastaliklarsempozyumu2017.org/default.asp?kid=1&alt_kid=0&alt_kid1=0
March 20th, 2017 – Meet CarthaGenetics® at Bio-Europe Spring
Carthagenetics® will attend Bio-Europe Spring on 20 – 22 March, 2017 in Barcelona, Spain. If you would like to arrange a one-to-one meeting with us, please send an email to our CEO, Philippe Carteron de Balmont (phcarteron@carthagenetics.com)
March 18th, 2017 – Meet CarthaGenetics® at 10ème journée nationale pharmaceutique
Carthagenetics® will attend 10ème journée nationale pharmaceutique on 18th March, 2017 at Hotel El Aurassi, Algeria: « LE PHARMACIEN & LA POLITIQUE NATIONALE DU MEDICAMENT » If you would like to arrange a one-to-one meeting with us, please send an email to Ms Imane Belala (belala@carthagenetics.com)
February 23rd, 2017 – Meet CarthaGenetics® at Global Health Event “A conversation with Ruth Dreifuss, High-Level Panel on Access to Medicine”
Carthagenetics® will attend this event on February 23rd, 2017 in Maison de la Paix, Geneva, Switzerland. If you would like to arrange a one-to-one meeting with us, please send an email to our CEO, Philippe Carteron de Balmont (phcarteron@carthagenetics.com)
February 13th, 2017 – Meet CarthaGenetics® at the 13th Annual World Symposium
CarthaGenetics® will attend the 13th Annual World Symposium, on February 13 – 17, 2017 in San Diego, California. If you would like to arrange a meeting with us please contact: Philippe Carteron at phcarteron@carthagenetics.com or Erhan Kaya at kaya@carthagenetics.com
February 10th, 2017 – Meet CarthaGenetics® at Rare Diseases International Policy Event
CarthaGenetics® will be attending the Rare Diseases International Policy Event on February 10th, 2017 in Switzerland, Geneva. If you would like to arrange a meeting with us during the congress, please contact: Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com
February 8th, 2017 – Meet CarthaGenetics® at the 3rd IRDiRC Conference
Carthagenetics® will attend the 3rd IRDiRC Conference on February 8th & 9th, 2017 in Paris, France. If you would like to arrange a one-to-one meeting with us, please send an email to Doctor Amir SHARAF (sharaf@carthagenetics.com) or Haythem AMMAR (ammar@carthagenetics.com)
December 21st, 2016 – Meet CarthaGenetics® at 13th Pharmaceutical Congress of Turkey
CarthaGenetics® will be attending the 13th Pharmacist Congress of the Turkish Pharmacist Association (TEB) in Istanbul, Turkey from December 21st till December 24th, 2016. This is the major congress for the topics related with pharmacy and pharmacist in Turkey. Turkish and international speakers from government, academy and private sector will present recent developments, updates and new approaches. If you would like to arrange a meeting with us during the congress, please contact: Erhan Kaya Riveraconteras at: kaya@carthagenetics.com, Filiz Cavus at: cavus@carthagenetics.com , or Guvenc Kockaya at: kockaya@carthagenetics.
November 29th, 2016 – Meet CarthaGenetics® at BIOLATAM 2016
CarthaGenetics® will be attending the 3rd Annual International Partening Conference BIOLATAM in San Juan, Puerto Rico on November 29th & 30th, 2016. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.
November 25th, 2016 – Meet CarthaGenetics® at 52nd Annual Congress of the Turkish Neurological Society
CarthaGenetics® will be attending the 52nd Annual Congress of the Turkish Neurological Society in Antalya, Turkey, from November 25th till December 1st, 2016. If you would like to arrange a meeting with us during the congress, please contact: Aroussi Bidani at: bidani@carthagenetics.com, Filiz Cavus at: cavus@carthagenetics.com , or Mustapha Aydin at: aydin@carthagenetics.com
November 24th, 2016 – 9th Pediatric Nephrology Congress in Antalya
CarthaGenetics® attended the 9th Pediatric Nephrology Congress held in Antalya, Turkey from 24th to 27th November, 2016. The congress was organized by the Pediatric Nephrology Association. Both Turkish and European speakers have presented the conventional and novel treatment approaches in kidney diseases in children.
November 24th, 2016 – Meet CarthaGenetics® at Refresh Europe 2016 in Paris
CarthaGenetics® will be attending Refresh Europe 2016 in Paris, France, on November 24th, 2016. Organized by Labiotech, this is Europe’s most refreshing biotech conference in its second edition.Come to get a deep insight into tomorrow’s Biotech trends in a dynamic and modern way, and meet with 250 of Europe’s Biotech leaders, innovators and enthusiasts. To arrange a short meeting with us at the event, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com and connect to this event at: http://labiotech.eu/refresh/
November 7th, 2016 – Meet CarthaGenetics® at BIO-Europe 2016 Cologne
CarthaGenetics® will be attending BIO-Europe 2016 in Cologne, Germany, on November 7-9th, 2016. This is the 22nd annual BIO-Europe event, the largest biotechnology partnering conference held in Europe. Over 3,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and deal makers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com or through the web-based partnering system at: https://ebdgroup.knect365.com/bioeurope/
November 2nd, 2016 – Meet CarthaGenetics® at Bio-Alps Networking Day 2016 in Geneva
CarthaGenetics® will be attending the Bio-Alps Networking Day 2016 in Geneva, Switzerland, on November 2nd, 2016. To arrange a short meeting with us at the event or after the event, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com and connect to this event at: http://m.bioalps.org/biotechno
October 4th , 2016 – Meet CarthaGenetics® at CPHI Worldwide 2016
CarthaGenetics® will be attending CPHI Worldwide 2016 Congress in Barcelona, Spain from October 4th-6th, 2016. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com
September 28th, 2016 – Meet CarthaGenetics® at BioSpain 2016
CarthaGenetics® will be attending the BioSpain 2016 Congress in Bilbao, Spain, from September 28th-30th, 2016. If you would like to arrange a meeting with us during the conference, please contact Naciba Zetchi, Area Director, Spain and Portugal, at: Zetchi@carthagenetics.com
September 13th, 2016 – Meet CarthaGenetics® at BioPharm America 2016
CarthaGenetics® will be attending the BioPharm America 2016 Congress in Boston, USA, from September 13th-15th, 2016. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at phcarteron@carthagenetics.com
September 6th, 2016 – Meet CarthaGenetics® at SSIEM Rome 2016
CarthaGenetics® will be attending the annual Symposium SSIEM in Rome, Italy, from September 6th-9th, 2016. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com
June 30th, 2016 – Meet CarthaGenetics® at MPS 2016 Bonn, Germany
CarthaGenetics® will be attending the MPS2016 congress in Bonn, Germany on July 13th-16th, 2016. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com
June 10th, 2016 – Meet CarthaGenetics® at Les Journées de Printemps SFEIM 2016, Grenoble
CarthaGenetics® will be attending Les Journées de Printemps de la SFEIM (Société Française des Erreurs Innées du Métabolisme) in Grenoble, France on June 17th-18th, 2016 If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com
May 3rd, 2016 – Meet CarthaGenetics® at Labiotech Refresh 2016 in Berlin
CarthaGenetics® will be attending the Labiotech Refresh 2016 in Berlin, Germany on April, 24th, 2016. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com
April 10th, 2016 – Meet CarthaGenetics® at the World Orphan Drugs Congress 2016 USA
CarthaGenetics® will be attending the World Orphan Drugs Congress 2016 USA, held at The Washington Hilton, Washington DC, from April 20th– 22nd, 2016. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com
April 8th, 2016 – Meet CarthaGenetics® at Lizozomal 2016 in Bodrum, Turkey
CarthaGenetics® will be attending Lizozomal 2016 in Bodrum, Turkey, from April 14th to 18th, 2016. If you would like to arrange a meeting with us during the conference, please contact Philippe Carteron de Balmont, CEO, at: phcarteron@carthagenetics.com
